Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-12-003670
Filing Date
2012-01-25
Accepted
2012-01-25 18:05:37
Documents
1
Period of Report
2012-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2220
  Complete submission text file 0001140361-12-003670.txt   3623
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Issuer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 33 KACHAL STREET LEHAVIM L3 85338
Business Address
Eliaz Rom E (Reporting) CIK: 0001540346 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54586 | Film No.: 12545714